The aim of this randomized placebo- controlled clinical trial is to evaluate the effects of Lactobacillus rhamnosus SP1- containing probiotic tablets as an adjunct to scaling and root planning (SRP). Material and methods: Thirty six chronic periodontitis patients will be recruited and monitored clinically, immunologically and microbiologically at baseline, 3 and 6 months after therapy. All patients will receive scaling and root planning and randomly will be assigned over an experimental (SRP + probiotic, n=18) or control (SRP + placebo, n=18) group. The tablets will be used once per day during 3 months.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
36
Tablet containing Lactobacillus rhamnosus SP1
Tablet containing talc powder
Scaling and root planning
Faculty of Dentistry of University of Chile
Santiago, Santiago Metropolitan, Chile
Differences of at least 1mm between groups for clinical attachment level changes
Time frame: baseline, 3, 6 months
Differences between groups for probing depth changes
Time frame: baseline, 3, 6 month
Differences between groups for bleeding on probing changes
Time frame: baseline, 3, 6 months
Differences between groups for plaque index changes
Time frame: baseline, 3, 6 months
Differences between groups for levels of Interleukin (IL)-17, IL-21, Transforming Growth Factor (TGF)- beta, IL-10, RANKL changes in gingival crevicular fluid
Time frame: baseline, 3, 6 months
Differences between groups for levels of periodontal pathogens changes
Time frame: baseline, 3, 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.